The Precision Peptide Company Inc.

Disclaimer and Forward Looking Statements

This website contains certain “forward-looking statements” and “forward-looking information” within the meaning of applicable Canadian securities legislation (collectively, “forward-looking statements”). All statements on this website, other than statements of historical fact, are forward-looking statements. Forward-looking statements include, but are not limited to, statements relating to:

• the Company’s corporate objectives, business strategy, and long-term aspirations, including its mission to expand access to next-generation peptide technologies;
• the Company’s research and development activities relating to its peptide-based formulations and drug delivery platforms, including its advanced transdermal and oral delivery systems;
• the anticipated applications and benefits of the Company’s peptide products and technologies;
• the Company’s plans to expand and scale its distribution network across North American clinical, consumer, and performance-driven markets;
• the anticipated market opportunity in the North American peptide-based wellness industry, including statements regarding the growth of the peptide segment;
• the Company’s plans to enter into licensing, partnership, collaboration, manufacturing, or other commercial agreements in connection with its products and delivery platforms;
• the Company’s plans with respect to future financing and the anticipated use of proceeds therefrom;
• expectations regarding revenues, expenses, and future financial performance; and
• any other information as to the future plans and outlook for the Company.

Forward-looking statements are frequently identified by words and phrases such as “aims,” “anticipates,” “believes,” “continues to,” “designed for,” “estimates,” “expects,” “focused on,” “forecasts,” “future,” “guidance,” “in development,” “intends,” “may,” “might,” “objective,” “outlook,” “plans,” “potential,” “projected,” “pursue,” “reimagined,” “scheduled,” “seeks,” “should,” “strategy,” “targets,” “will,” “will be achieved,” “will occur,” or variations of such words and expressions, or statements that certain actions, events, or results “could,” “would,” or “might” occur. Forward-looking statements are based on the current expectations, estimates, assumptions, and beliefs of management as of the date the relevant statement is made and are necessarily subject to a number of risks, uncertainties, and other factors.

Forward-looking statements are not guarantees of future performance. They involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, without limitation:

• the early-stage nature of the Company’s product development activities, including the transdermal delivery platform currently under development, and the inherent uncertainties associated therewith;
• the ability to obtain, maintain, and enforce any patents or other intellectual property rights in respect of the Company’s product formulations and delivery technologies;
• competition from other companies with greater resources, more established distribution networks, and more advanced product pipelines in the peptide wellness and biopharmaceutical sectors;
• the ability to scale the Company’s distribution network across North America as anticipated and to respond to changes in consumer demand for peptide-based wellness solutions;
• the potential for adverse regulatory action in Canada, the United States, or other applicable jurisdictions in respect of the Company’s peptide products, including actions by Health Canada, the U.S. Food and Drug Administration, or the Federal Trade Commission relating to product classification, health claims, or advertising practices;
• changes in laws and regulations applicable to natural health products, consumer wellness products, drug development, and advertising;
• the availability of financing on acceptable terms, or at all, to fund the Company’s operations, product development, and distribution expansion;
• the impact of general economic and market conditions, including inflation and interest rate fluctuations, on consumer demand for wellness products;
• reliance on third-party contract manufacturers, researchers, distributors, and other service providers;
• risks associated with peptide synthesis and manufacturing scale-up, including challenges in maintaining purity, potency, and identity across production batches;
• foreign exchange fluctuations, given the Company’s operations and market focus across Canada and the United States; and
• other risk factors described in the Company’s public filings available on SEDAR+ at www.sedarplus.ca.

The above list of risk factors is not exhaustive. Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, actual results to differ materially from those expressed or implied in any forward-looking statements.

Readers and investors are cautioned not to place undue reliance on forward-looking statements, as actual results and future events could differ materially from those anticipated in such statements. The forward-looking statements contained on this website are made as of the date this website was published and are expressly qualified in their entirety by this cautionary note. Except as required by applicable Canadian securities laws or the policies of the Canadian Securities Exchange, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.